JPS6026546B2 - body fluid filtration device - Google Patents

body fluid filtration device

Info

Publication number
JPS6026546B2
JPS6026546B2 JP55100663A JP10066380A JPS6026546B2 JP S6026546 B2 JPS6026546 B2 JP S6026546B2 JP 55100663 A JP55100663 A JP 55100663A JP 10066380 A JP10066380 A JP 10066380A JP S6026546 B2 JPS6026546 B2 JP S6026546B2
Authority
JP
Japan
Prior art keywords
body fluid
membrane
furnace
core material
filtrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55100663A
Other languages
Japanese (ja)
Other versions
JPS5725858A (en
Inventor
章 猪狩
勉 村上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP55100663A priority Critical patent/JPS6026546B2/en
Priority to AU72834/81A priority patent/AU526959B2/en
Priority to US06/283,518 priority patent/US4401566A/en
Priority to EP81105701A priority patent/EP0045033B1/en
Priority to DE8181105701T priority patent/DE3172606D1/en
Priority to ES504111A priority patent/ES8204298A1/en
Priority to CA000382020A priority patent/CA1174606A/en
Priority to BE0/205460A priority patent/BE889694A/en
Publication of JPS5725858A publication Critical patent/JPS5725858A/en
Publication of JPS6026546B2 publication Critical patent/JPS6026546B2/en
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • B01D65/08Prevention of membrane fouling or of concentration polarisation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08Flat membrane modules
    • B01D63/082Flat membrane modules comprising a stack of flat membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08Flat membrane modules
    • B01D63/082Flat membrane modules comprising a stack of flat membranes
    • B01D63/084Flat membrane modules comprising a stack of flat membranes at least one flow duct intersecting the membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2321/00Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
    • B01D2321/20By influencing the flow
    • B01D2321/2008By influencing the flow statically

Description

【発明の詳細な説明】 11発明の背景 技術分野 本発明は、腎不全患者等の治療を効率よくおこなうため
の炉過型人工腎臓等の体液炉過装置に関する。
DETAILED DESCRIPTION OF THE INVENTION 11. Background Technical Field of the Invention The present invention relates to a body fluid filtration device such as a filtration type artificial kidney for efficiently treating patients with renal failure.

先行技術 近時、透析困難な腎不全患者等に対して血液炉過による
治療が普及しつつあり、そのための炉過型人工腎臓の開
発が強く要望されている。
BACKGROUND OF THE INVENTION Recently, the treatment of renal failure patients for whom dialysis is difficult has become widespread, and there is a strong demand for the development of an artificial kidney using a blood furnace for this purpose.

血液炉過治療では、体外に排出される炉液量が、20〜
25そ/6時間必要といわれ、それゆえ人工腎臓は56
〜70の‘/minの炉過特性が必要とされる。従来の
涙過型人工腎臓には、複数のフアィバーを配設したホロ
ーフアィバ型のものと、複数の平膜状炉過膜を設けて炉
週をおこなう積層型のものとがあるが、装置の炉過特性
、大きさ、製造コスト等に問題がある。すなわちこの種
人工腎臓の炉過特性は、炉過膜の材質、血液流量等とも
に血液の流路厚に大きく依存し、これを薄くすることに
よって炉過量を大きくとることができる。
In blood reactor overtreatment, the amount of reactor fluid excreted outside the body is 20~
It is said that it takes 25 to 6 hours, so the artificial kidney requires 56 hours.
A furnace filtration rate of ~70'/min is required. Conventional lachrymal artificial kidneys include a hollow fiber type with multiple fibers and a stacked type with multiple flat membranes for heating. There are problems with excessive characteristics, size, manufacturing cost, etc. That is, the filtration characteristics of this type of artificial kidney largely depend on the thickness of the blood flow path, as well as the material of the filtration membrane, the blood flow rate, etc., and by making these thinner, the filtration rate can be increased.

しかしホローフアイバー型のものでは、製造上ファィバ
ー内径を小さくすることには限界があり、せいせい20
0r程度である。この結果所望の炉適量を得がたいのみ
ならず、壁せん断速度が小さくなり隈面に付着した蛋白
等で炉適量が経時的に減少し、又分画分子量も経時的に
変化するおそれがある。これに対し、従来の積層型のも
のは、スベーサを用いて炉過膜間の間隙(流路厚)を規
制しているため、流路厚を均一に設定することが難かし
く、しかも膿間厚を薄く調節することは困難であり、こ
のものにおいて炉過特性を高めることは驚かしい。
However, with the hollow fiber type, there is a limit to reducing the inner diameter of the fiber due to manufacturing reasons.
It is about 0r. As a result, it is not only difficult to obtain the desired amount in the furnace, but also the wall shear rate decreases, and the amount in the furnace decreases over time due to proteins adhering to the wall surface, and the molecular weight fraction may also change over time. On the other hand, the conventional laminated type uses a smoother to regulate the gap (channel thickness) between the filter membranes, which makes it difficult to set the channel thickness uniformly. It is difficult to adjust the thickness to be thin, and it is surprising to improve the filtration characteristics in this product.

このようなことから従釆は、この種の体液炉過装置を2
連接続し、あるいは装置の膜面積を大きくするなどの手
段を講じて炉適量を得るようにしているが、この場合装
置が大型になり、コストも高くなるなどの欠点がある。
For this reason, we have decided to install two body fluid filtration devices of this type.
Although measures such as continuous connection or enlarging the membrane area of the device are used to obtain the appropriate amount for the furnace, there are disadvantages in this case, such as the size of the device and the high cost.

このような事情に鑑み、本出願人は、第1図に示す如く
、人工腎臓として網目状芯材1の両面に炉過膜2を設け
て膜ユニット3を形成し、複数の腰ユニット3をケース
4内に積層したものを先に提案した。この人工腎臓は、
各炉過膜2が芯材1の凹凸面に沿う波形状となっており
、膿ユニット3間に体液(例えば血液)流路5を形成し
て、ここを通る血液の炉過をおこなうものである。しか
し上記人工腎臓では、同一の材質、形状、寸法のものを
作製して、血液の通路条件を同じとしても所定の炉過量
を得られないものが多く、そのばらつきが多い問題があ
った。このことから本発明者はこの原因を調べた結果、
芯材が網目状に編まれているために血液の流通しやすい
方向と流通しにくい方向とがあり、この結果所定の炉過
量を得ることができないことが判明した。
In view of these circumstances, the present applicant provided a filter membrane 2 on both sides of a mesh core material 1 to form a membrane unit 3 as an artificial kidney, as shown in FIG. We previously proposed a layered structure inside Case 4. This artificial kidney is
Each filtration membrane 2 has a wave shape that follows the uneven surface of the core material 1, and forms a body fluid (for example, blood) flow path 5 between the pus units 3, through which blood is filtered. be. However, in the above-mentioned artificial kidneys, even if they are made of the same material, shape, and size and the blood passage conditions are the same, many of them fail to obtain a predetermined furnace overflow, and there is a problem that there are many variations. Based on this, the inventor investigated the cause and found that
It has been found that because the core material is woven into a mesh, there are directions in which blood flows easily and directions in which it does not flow easily, and as a result, it is not possible to obtain a predetermined excess amount in the furnace.

すなわち芯材を構成する素線に沿う方向では血液流路が
直線的で短かくここに多くの血液が流通しやすいのに対
し、例えば素線45oをなす皿流の方向では血液流路が
ジグザグ状で長くなり、ここに血液が流通し難く、この
結果所定の炉過量を得ることができない。
In other words, in the direction along the strands that make up the core material, the blood flow path is straight and short, making it easy for a large amount of blood to flow there, whereas in the dish flow direction that forms the strand 45o, for example, the blood flow path is zigzag. This makes it difficult for blood to circulate there, and as a result, it is not possible to obtain a predetermined furnace overflow.

0 発明の目的 本発明は上記事情に鑑みてなされたもので、その目的と
するところは、隣接する芯材の素線の方向を変えること
により、各周方向への血液流路の流通条件を均一化しも
って所定の炉過量をばらつきなく得ることができる体液
炉過装置を得んとするものである。
0 Purpose of the Invention The present invention has been made in view of the above circumstances, and its purpose is to change the flow conditions of the blood flow path in each circumferential direction by changing the direction of the strands of adjacent core materials. It is an object of the present invention to provide a body fluid filtration device which can uniformly obtain a predetermined filtration amount without variation.

ここで、ばらつきとは平均炉過量に対して上下何パーセ
ントの炉過量のぱらつきがあったかを意味する。
Here, the dispersion means the percentage above and below the average furnace overflow that varies in the furnace overflow.

すなわち本発明は、炉液が芯材内の間隙を通過出釆るよ
うにした網目状芯村の全面を炉過膜で被覆し該炉過膿の
少なくとも1ケ所に炉液流出口を設けた膿ユニットの複
数個を重ね合わせ、体液流入口と炉液出口と体液流出口
とを設けたケース内に配設した体液炉過装置において、
各膜ユニットの炉液流出口をケースの炉液流出口に連通
させ、かつ一方の膜ユニットの芯村を構成する任意の素
線とこれに隣接する他方の膿ユニットの芯材を構成する
任意の素線とのなす角度を30〜60oとなすように膿
ユニットを配設し、上記ケースの体液流入口から注入さ
れる体液が膿ユニット間の体液流略を通り炉過膜で炉過
され、炉過膜を介して膿ユニット内に流入した炉液は網
目状芯〆オの間隙を通過し、さらに膿ユニットの炉液流
出口を経てケースの炉液出口から流出し、一方体液流路
を通った炉過残液はケースの体液流出口から流出するよ
うにしたことを特徴とする体液炉過装置である。
That is, in the present invention, the entire surface of the mesh-like core village in which the furnace liquid passes through the gaps in the core material is covered with a furnace filter membrane, and a furnace liquid outlet is provided at at least one location of the furnace liquid. In a body fluid filtering device in which a plurality of pus units are stacked one on top of the other and arranged in a case provided with a body fluid inlet, a furnace fluid outlet, and a body fluid outlet,
The furnace fluid outflow port of each membrane unit is communicated with the furnace fluid outflow port of the case, and any strands constituting the core village of one membrane unit and any wire constituting the core material of the other pus unit adjacent thereto The phlegm units are arranged so that the angle with the strands of the pus units is 30 to 60 degrees, and the body fluid injected from the body fluid inlet of the case passes through the body fluid flow path between the pus units and is filtered by the filter membrane. The fluid that has flowed into the phlegm unit through the filtration membrane passes through the gap between the mesh wicks, passes through the wick outlet of the phlegm unit, and flows out from the fluid outlet of the case, while the body fluid flow path This body fluid furnace filtration device is characterized in that the residual fluid passed through the furnace flows out from the body fluid outlet of the case.

又本発明は、芯材のオープニングを700〜1300仏
としたものである。又本発明は、芯材を糸径300〜3
50rの素線で1奴当りの糸数7〜9本の割合で編んだ
ものである。
Further, in the present invention, the opening of the core material is set to 700 to 1300 Buddha. Further, in the present invention, the core material has a thread diameter of 300 to 3
It is knitted with 50r strands at a ratio of 7 to 9 threads per yarn.

又本発明は、炉過膜が芳香族ポリアミドを主成分とする
分画分子量20000〜65000で膜厚30〜300
ムの膜からなり、ポリエチレン、ポリプロピレンの不織
布からなる膿支持体を裏打ちしたものである。
Further, in the present invention, the furnace membrane is mainly composed of aromatic polyamide, has a molecular weight cut-off of 20,000 to 65,000, and has a film thickness of 30 to 300.
The membrane is lined with a pus support made of nonwoven polyethylene or polypropylene fabric.

更に本発明は、ケース内の膜ユニットが気密に摺接する
ピストンを介して弾性部材で押圧されたものである。
Furthermore, in the present invention, the membrane unit inside the case is pressed by an elastic member via a piston that slides into airtight contact.

なおここでオープニングは以下に定義されたものをいう
Note that opening here is defined below.

o=ノab o:オープニング a:素線で区画された矩形状又は正方形状の空間の縦の
長さb:同空間の横の長さ m 発明の具体的説明 以下本発明を図示する人工腎臓にもとづいて説明する。
o=No ab o: Opening a: Vertical length of a rectangular or square space partitioned by wires b: Horizontal length of the space m Detailed Description of the Invention The following is an artificial kidney illustrating the present invention. I will explain based on this.

第2図は人工腎臓の断面図で、この人工腎臓はケース1
1内に複数の膜ユニット12…を積層して収容している
。上記ケース11はスチロール樹脂等の合成樹脂で円筒
状に形成され、その底部中央に血液等の体液流入口11
a,底部周緑に炉液出口11bを設け、さらに側面に血
液等の体液流出口11cを設けている。またケース11
の上部関口端には、積層した膜ユニット12・・・を押
圧するピストン13が設けられている。このピストン1
3は外周面にシリコーン樹脂からなる○リング14,1
4を設けており、ケース11内周面を気密に溶接するよ
うになっている。またピストン13の上部にはこれを押
圧する圧縮コイル‘まねの弾性部材15が設けられてい
る。更にケース11の上端外周面には調節リング16が
装着され、ピストン13の上方への移動を規制している
。しかして上記ケース11内に収容する各勝ユニット1
2は、第3図及び第4図に示すように、網目状芯材17
の両面に炉過膜18,18を設けている。
Figure 2 is a cross-sectional view of the artificial kidney, and this artificial kidney is shown in Case 1.
A plurality of membrane units 12 are stacked and housed in the membrane unit 1. The case 11 is made of synthetic resin such as styrene resin and has a cylindrical shape, and has a body fluid inlet 11 such as blood at the center of the bottom.
a. A furnace liquid outlet 11b is provided on the bottom periphery, and an outlet 11c for body fluids such as blood is provided on the side. Also case 11
A piston 13 for pressing the stacked membrane units 12 is provided at the upper end of the entrance. This piston 1
3 is a ring 14, 1 made of silicone resin on the outer peripheral surface.
4, and the inner peripheral surface of the case 11 is welded airtightly. Further, an elastic member 15 imitating a compression coil is provided at the upper part of the piston 13 to press it. Further, an adjustment ring 16 is attached to the outer circumferential surface of the upper end of the case 11 to restrict upward movement of the piston 13. Therefore, each winning unit 1 accommodated in the case 11
2, as shown in FIGS. 3 and 4, a mesh core material 17
Furnace membranes 18, 18 are provided on both sides of the filter.

上記芯材17は、ポリエステル、ポリエチレン等からな
る素線を編んだ円板状のものである。この芯材17は炉
過膜によって炉過された炉液が通る通路として芯材17
,.172 により間隙が形成されまた芯材17の網目
のオープニングは、小さすぎると炉過量を十分とれず、
又大きすぎると柔軟となって変形しやすくかつ又体液流
路厚が厚くなり重ね合せた際に体液の流離を形成し難く
、所定の炉適量も得られないため通常700〜1300
ムとするのが好適である。上記範囲のオープニングを得
るためには、糸径300〜350ムの素線を用い、1の
当りの糸数を7〜9本として編むのが、製造上適当であ
る。1仇当りの糸数が9本を越えると、炉過量を十分と
れず、また7本末満であると体液流路厚が厚くなり、体
液流路を形成し驚いため炉過重を十分とれない。
The core material 17 is a disk-shaped material made of woven wires made of polyester, polyethylene, or the like. This core material 17 serves as a passage through which the furnace liquid filtered by the furnace filter membrane passes.
、. 172, and if the opening of the mesh of the core material 17 is too small, the furnace overload cannot be sufficiently taken.
Also, if it is too large, it will become flexible and easily deform, and the body fluid flow path will become thick, making it difficult to form a separation of body fluids when stacked and making it impossible to obtain a predetermined appropriate amount in the furnace.
It is preferable that the In order to obtain an opening in the above range, it is suitable for production to use strands with a thread diameter of 300 to 350 mm and knit with 7 to 9 threads per thread. If the number of threads per thread exceeds 9, the furnace overload cannot be sufficiently taken, and if it is less than 7 threads, the thickness of the body fluid flow path becomes thick, forming a body fluid flow path and causing surprise, so that the furnace overload cannot be taken sufficiently.

上記炉過膜18は、芳香族ポリアミドを主成分とする分
画分子量20000〜65000で膜厚30〜300山
のもので、相分離法、抽出法等で製膜されたものである
The filter membrane 18 is made of aromatic polyamide as a main component, has a molecular weight cut-off of 20,000 to 65,000, and has a thickness of 30 to 300 membranes, and is formed by a phase separation method, an extraction method, or the like.

膜厚が30山未満であると、膜強度が低下し、300仏
を越えると炉過性能が落ちる。この炉過膜18には、第
5図に示すようにポリエチレン、ポリプロピレンの不織
布からなる膿支持体19を裏うちしている。この腹支持
体19は、膜の強度を高めるものである。上記芯村オー
7と炉過膜18,18とを粗合せてた膜ユニット12は
、第2図に示すように中央部に体液流入口12aを、周
縁部に炉液流出口12bをそれぞれ設けたもので、炉過
膜18,18の周緑及び体液流入口12aの周縁にある
膿支持体19,19相互をそれぞれ熱葛虫着、超音波融
着、接着剤等により接合している。
If the film thickness is less than 30 mm, the film strength will decrease, and if it exceeds 300 mm, the furnace overflow performance will decrease. As shown in FIG. 5, this filter membrane 18 is lined with a pus support 19 made of a nonwoven fabric of polyethylene or polypropylene. This belly support 19 increases the strength of the membrane. The membrane unit 12, in which the core membrane O 7 and the furnace membranes 18, 18 are roughly combined, has a body fluid inlet 12a at the center and a furnace fluid outlet 12b at the periphery, as shown in FIG. The peripheries of the filter membranes 18, 18 and the pus supports 19, 19 at the periphery of the body fluid inlet 12a are bonded to each other by heat bonding, ultrasonic fusion, adhesive, etc., respectively.

ここで熱融着の場合は140〜14ぴCの温度で3〜4
k9/地の圧力でおこなっている。更に炉液流出口12
bの周縁にはリング状シール材20が接着されている。
このシ−ル材20は、例えば基材両面にアクリル樹脂を
塗布したアクリル系両面テープあるいは基材両面に合成
ゴム系ホットメルトを塗布したホットメルト系両面テー
プなどである。このシール材20は、隣接する膜ユニッ
ト12の炉液流出口12b間を血液流路21から閉塞す
るものでその厚さは通常150〜200ムである。更に
上記膜ユニット12の芯村17を構成する素線と、隣接
する膜ユニット12の芯材17を構成する素線とのなす
角度を30〜6ぴとしている。
In the case of heat fusion, the temperature is 140 to 14 picC and the temperature is 3 to 4.
k9/It is performed using the pressure of the earth. Furthermore, the furnace liquid outlet 12
A ring-shaped sealing material 20 is adhered to the periphery of b.
This sealing material 20 is, for example, an acrylic double-sided tape with an acrylic resin coated on both sides of a base material, or a hot-melt double-sided tape with a synthetic rubber hot melt coated on both sides of the base material. This sealing material 20 closes off the blood flow path 21 between the reactor fluid outflow ports 12b of adjacent membrane units 12, and its thickness is usually 150 to 200 mm. Furthermore, the angle between the strands forming the core village 17 of the membrane unit 12 and the strands forming the core material 17 of the adjacent membrane unit 12 is set to 30 to 6 degrees.

例えば図示する実施例では、一方の膜ユニット12,は
、第6図に示すように体液流入口12aと炉液流出口1
2bとを結ぶ直線が素線の方向に沿う(又は秦線と直角
方向)ように炉液流出口12bが形成される。これに対
し、隣接する膜ユニット122は、第7図に示すように
体液流入口12aと炉液流出口12bとを結ぶ直線が黍
線の方向と45oで交わるように形成され、両膜ユニッ
ト12,,122 の芯材17の素線がなす角度8を4
5oとしている。角度aが300未満又は600を越え
ると、所望の炉過重を得がたく、しかも炉過量のぱらつ
きが大きくなる。このように構成された人工腎臓は、例
えば第8図に示すように組込まれて血液炉過回路を形成
する。
For example, in the illustrated embodiment, one membrane unit 12 has a body fluid inlet 12a and a furnace fluid outlet 1, as shown in FIG.
The furnace liquid outlet 12b is formed such that the straight line connecting the wires 12b and 2b runs along the direction of the strands (or in a direction perpendicular to the line). On the other hand, the adjacent membrane units 122 are formed so that the straight line connecting the body fluid inlet 12a and the furnace fluid outlet 12b intersects the direction of the millet line at 45o, as shown in FIG. ,,122 The angle 8 formed by the strands of the core material 17 is 4
It is set at 5o. When the angle a is less than 300 or exceeds 600, it is difficult to obtain the desired furnace overload, and the fluctuation in the furnace overload increases. The artificial kidney thus constructed is assembled, for example, as shown in FIG. 8 to form a blood reactor overcircuit.

すなわちこの回路は体液流入口11aに血液ポンプ2、
動脈チャンバー23を備えた血液流入管24を取付け、
体液流出口11cに静脈チャンバー25を備えた血液流
出管26を取付け、又上記静脈チャンバー25に補液ポ
ンプ27を備えた補液供V給管28を取付け、更に炉液
出口1 1bに陰圧ポンプ29を備えた炉液排出管30
を取付けている。W 発明の具体的作用 第8図に示す血液炉過回路において、人体からの体液、
たとえば血液A,が血液流入管24、体液流入口11a
を通ってケース11内に入ると、膿ユニット12間の体
液(例えば血液)稀路21を通り、炉過膿18により炉
液分離される。
That is, this circuit includes a blood pump 2 and a body fluid inlet 11a.
attaching a blood inflow tube 24 with an arterial chamber 23;
A blood outflow pipe 26 equipped with a venous chamber 25 is attached to the body fluid outlet 11c, a replacement fluid supply V supply pipe 28 equipped with a replacement fluid pump 27 is attached to the venous chamber 25, and a negative pressure pump 29 is attached to the furnace fluid outlet 11b. Furnace liquid discharge pipe 30 equipped with
is installed. W. Specific operation of the invention In the blood reactor overcircuit shown in FIG. 8, bodily fluids from the human body,
For example, blood A is transferred to the blood inflow pipe 24 and the body fluid inlet 11a.
When entering the case 11 through the passageway, body fluids (for example, blood) pass through a passage 21 between the pus units 12 and are separated by the pus 18.

炉液である血※成分を分離した後の血球成分を含む血液
A2は、体液流出口11c、血液流出管26を経て補液
とともに人体に戻される。また膜ユニットの炉過膜18
で分離ごた血数成分は芯材17,,172内の間隔を通
り膿ユニットの炉液流出口12bに到り、各膜ユニット
内で炉過された炉液Bが合流し、炉液出口116、炉液
排出管30を通って排出される。V 発明の具体的効果 (iー この構成の体液炉過装置は、隣接する芯材の素
線のなす角度を30〜60oとくに4yとすることによ
り、各周方向に対して均一な体液(例えば血液)流路2
1を確保して、所望する涙過量をばらつきを生ずること
なく得ることができる。
Blood A2 containing blood cell components after the blood* component which is the furnace fluid has been separated is returned to the human body together with replacement fluid through the body fluid outlet 11c and the blood outflow pipe 26. In addition, the furnace filtration membrane 18 of the membrane unit
The separated blood components pass through the gaps in the core materials 17, 172 and reach the furnace liquid outlet 12b of the pus unit, where the furnace liquid B filtered in each membrane unit joins and flows through the furnace liquid outlet. 116, and is discharged through the furnace liquid discharge pipe 30. V. Specific Effects of the Invention (i) The body fluid filtration device having this configuration has a uniform body fluid in each circumferential direction (e.g. blood) flow path 2
1, the desired lacrimal volume can be obtained without any variation.

すなわち隣接する芯材の黍線が重なり合っていると、先
に述べたように秦線に沿う方向に対して血液が流れやす
く、これと450なす方向に対して血液が流れにくい。
In other words, when the grain lines of adjacent core materials overlap, as mentioned above, blood tends to flow in the direction along the grain lines, and it is difficult for blood to flow in the direction 450 intersecting with the grain lines.

従って一方の膜ユニットの血液が流れやすい方向(秦線
に沿う方向)に対して他方の膜ユニットの血液が流れに
くい方向(素線と45oの方向)が重なるようにすれば
、血液の流れやすさが各方向で均一となるものである。
このことは以下の実験例で確認された。実験例 1 <体液炉過装置の構成> 炉過膜:材質 ポリエチレン不織布を裏打ちした芳香族
ポリアミド膜、外径10仇駁で、内径1仇奴ぐ 面積146c濯、接合法ヒートシール血 液においてのデータ‐95%分画分子 量50,000、膜厚210山 芯 材:材質 ポリエチレン 糸径245山、糸数8本/仇 オープニング925ム、 隣接する秦線のなす角度30〜6ぴ 膜ユニットの総面積:0.25〜04M2<実験方法> 新鮮牛血をプラズマ希釈してへマクリット値(Ht)2
0%、総タンパク量(T・P)7.0夕/dそに調整し
、この血液を検液として隣接する芯材の秦線のなす角度
を変えて炉過量を測定した。
Therefore, if the direction in which blood flows easily in one membrane unit (direction along the Qin line) and the direction in which blood in the other membrane unit does not flow easily (direction of the wire and 45o) overlap, blood will flow more easily. The thickness is uniform in all directions.
This was confirmed in the following experimental example. Experimental example 1 <Configuration of body fluid filtration device> Furnace filtration membrane: Material Aromatic polyamide membrane lined with polyethylene nonwoven fabric, outer diameter 10mm, inner diameter 1mm area 146 cm, bonding method heat seal blood data. -95% molecular weight cut off 50,000, membrane thickness 210 strand core Material: Material Polyethylene thread diameter 245 strands, number of threads 8/opening 925 mm, angle between adjacent Qin wires 30-6 dia Total area of membrane unit: 0.25-04M2 <Experimental method> Fresh bovine blood is diluted with plasma to obtain hemacrit value (Ht)2
The total protein content (T·P) was adjusted to 0% and the total protein content (T·P) was 7.0 m/d, and the furnace overload was measured by using this blood as a test solution and changing the angle formed by the lines of the adjacent core material.

その結果を第1表に示す。また、これと比較するために
、隣接する芯材オの素線のなす角度が本発明の範囲から
外れたものを比較例とし、素線が全く重なり合って、素
線と黍線のなす角度が00のものを参考例として、それ
らの結果を第1表に併記する。第1表 <実験結果> 上表によれば、本発明に係るものは膜ユニットの周方向
に流れる血液の流路条件が、各方向に対して略均一とな
るため、所定の炉過量が得られ、かつ炉過量のばらつき
を少なくすることが認められた。
The results are shown in Table 1. In addition, in order to compare with this, a case where the angle formed by the strands of the adjacent core material O is outside the scope of the present invention is used as a comparative example, and the strands completely overlap and the angle between the strands and the millet wire is 00 as a reference example, the results are also listed in Table 1. Table 1 <Experimental Results> According to the above table, in the device according to the present invention, the flow path conditions for blood flowing in the circumferential direction of the membrane unit are approximately uniform in each direction, so that a predetermined furnace overflow can be obtained. It was also confirmed that the variation in furnace overload was reduced.

(ii)また本発明では、芯村の網目のオープニングを
700〜1300ムとすることにより、最適の炉過量を
得ることができる。
(ii) Furthermore, in the present invention, by setting the opening of the core mesh to 700 to 1300 mm, an optimum furnace overload can be obtained.

このことは以下の実験例で認められた。実験例 2 実験例1で用いた炉過膜において、芯材のオープニング
を1572〜660″範囲で変えたものを用いて、体液
炉過装置を構成した。
This was confirmed in the following experimental examples. Experimental Example 2 A body fluid filtration device was constructed using the filtration membrane used in Experimental Example 1, with the opening of the core material varied in the range of 1572 to 660''.

この体液炉過装置に、Ht20、T・P3.0タノその
新鮮牛血を流量6〜7の【/minで流通せしめて炉過
量を測定した。
Fresh bovine blood of 20 Ht and 3.0 T.P was passed through this body fluid filtration device at a flow rate of 6 to 7/min, and the filtration amount was measured.

オープニングと炉過量との関係を第9図に示す。第9図
に示す測定結果によれば700〜1300Aで最適の炉
過量を得ることがわかる。
Figure 9 shows the relationship between opening and furnace overflow. According to the measurement results shown in FIG. 9, it can be seen that the optimum furnace overflow can be obtained at 700 to 1300A.

(iii) 又本発明では炉過膜として芳香族ポリアミ
ド膜を用いたものが炉過特性が優れている。
(iii) Furthermore, in the present invention, the filter using an aromatic polyamide membrane as the filter membrane has excellent filter characteristics.

このことは以下の実験例で認められた。実験例 3 実験例1で用いた材質の膜ユニットを用いてその分画分
子量を測定した。
This was confirmed in the following experimental examples. Experimental Example 3 A membrane unit made of the material used in Experimental Example 1 was used to measure its molecular weight fraction.

その結果生理食塩溶液では、各指標物質の阻止率は牛血
清−アルブミンで96〜97%、チトクロームCで15
〜18%、イヌリンで5〜7%、ビタミンB2で0〜2
%、BUNで0%であり、分画分子量はMW50,00
0〜60,000であった。また、Ht25%、T・P
3.5タノdその新鮮牛血では各指標物質の阻止率は、
牛血清−アルブミンで聡〜100%、チトクロームCで
60〜65%、イヌリンで30〜35%、ビタミンB8
で2〜5%、BUNで0%であり、分画分子量はMW4
0000〜50000であった。この結果から芳香族ポ
リアミド膜は、アルブミン(MW69000)がほとん
ど通過せず、それ以下の分子量の物質は多く通過するの
で血液の炉過に好適であることがわかる。
As a result, in physiological saline solution, the inhibition rate of each indicator substance was 96-97% for bovine serum albumin and 15% for cytochrome C.
~18%, inulin 5-7%, vitamin B2 0-2
%, BUN is 0%, and the molecular weight cutoff is MW50,00.
It was 0 to 60,000. In addition, Ht25%, T・P
3.5 In fresh bovine blood, the inhibition rate of each indicator substance is:
Bovine serum - albumin ~100%, cytochrome C 60~65%, inulin 30~35%, vitamin B8
2-5% for BUN, 0% for BUN, and the molecular weight cutoff is MW4.
It was 0000-50000. From these results, it can be seen that the aromatic polyamide membrane is suitable for blood filtration because almost no albumin (MW 69,000) passes through it, and many substances with a molecular weight lower than that pass through it.

また本発明によれば、炉過膜ごをポリエチレン、ポリプ
ロピレンの不織布からなる膜支持体で裏打ちしているの
で、炉過膜相互のシールをこの膿支持体でおこなうこと
ができ、炉過膜相互のシールが容易かつ確実であるとと
もに加工性に優れている。
Further, according to the present invention, since each furnace membrane is lined with a membrane support made of a nonwoven fabric of polyethylene or polypropylene, the membranes can be sealed with this support, and the furnace membranes can be mutually sealed. It is easy and reliable to seal, and has excellent workability.

また本発明は、0リングを備えたピストンで炉過膜への
押圧力を任意に調整できるので、この押圧力を調整する
ことにより血液流離厚を可能な限り小さくして、炉過量
を多くとることができる。
In addition, in the present invention, the pressure force applied to the furnace filtration membrane can be arbitrarily adjusted using the piston equipped with the O-ring, so by adjusting this pressure force, the blood flow separation thickness can be made as small as possible, and the furnace excess amount can be increased. be able to.

さらにまたピストンは圧縮コイルばねである弾性部材1
5で弾性的に押圧されているので、装置内に流入する血
液の脈動に応じて血液流路厚も変化し、安全性に優れて
いる。図面の簡単な説明 一 第1図は先に提示した人工腎臓の要部断面図、第2図は
人工腎臓の断面図、第3図は膜ユニットの断面図、第4
図は膜ユニットの平面図、第5図は第3図の一部拡大図
、第6図及び第7図は本発明に係る2種類の膜ユニット
を示す一部切欠平面図、第8図は第2図の人工腎臓を組
込んだ炉過回路の説明図、第9図はオープニングと炉過
量との関係を示す特性図である。
Furthermore, the piston is an elastic member 1 which is a compression coil spring.
5, the thickness of the blood flow path changes according to the pulsation of blood flowing into the device, resulting in excellent safety. Brief explanation of the drawings - Figure 1 is a sectional view of the main parts of the artificial kidney presented earlier, Figure 2 is a sectional view of the artificial kidney, Figure 3 is a sectional view of the membrane unit, and Figure 4 is a sectional view of the membrane unit.
5 is a partially enlarged view of FIG. 3, FIGS. 6 and 7 are partially cutaway plan views showing two types of membrane units according to the present invention, and FIG. 8 is a plan view of the membrane unit. FIG. 2 is an explanatory diagram of a furnace overflow circuit incorporating an artificial kidney, and FIG. 9 is a characteristic diagram showing the relationship between opening and furnace overflow.

11……ケース、12……腰ユニット、12a・・・…
体液流入口、12b・・・・・・炉液流出口、11a・
・・・・・体液流入口、11b・・・・・・炉液出口、
11c・・・・・・体液流出口、13・・・・・・ピス
トン、14・・・・・・○リング、15…・・・弾性部
材、16・・・・・・調節リング、17・・・・・・芯
材、18・・・・・・炉過膜、19・・・・・・膜支持
体、20・・・・・・シール材、21・・・・・・血液
流路、22…・・・血液ポンプ、23・…・・動脈チャ
ンバー、24・・…・血液流入管、25・・・・・・静
脈チャンバー、26・・・・・・血液流出管、27・・
・・・・補液ポンプ、28・・・・・・補液供給管、2
9・・・・・・陰圧ポンプ、30・・・・・・炉液排出
管。
11...Case, 12...Waist unit, 12a...
Body fluid inlet, 12b... Furnace fluid outlet, 11a.
... Body fluid inlet, 11b ... Furnace liquid outlet,
11c... Body fluid outlet, 13... Piston, 14...○ ring, 15... Elastic member, 16... Adjustment ring, 17. ... Core material, 18 ... Furnace filtration membrane, 19 ... Membrane support, 20 ... Seal material, 21 ... Blood flow path , 22... Blood pump, 23... Arterial chamber, 24... Blood inflow pipe, 25... Venous chamber, 26... Blood outflow pipe, 27...
... Replacement fluid pump, 28 ... Replacement fluid supply pipe, 2
9... Negative pressure pump, 30... Furnace liquid discharge pipe.

第1図 第2図 第3図 第4図 第5図 第6図 第7図 第8図 図 〇 船,Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 figure 〇 ship,

Claims (1)

【特許請求の範囲】 1 ろ液が芯材内の間隙を通過出来るようにした網目状
芯材の全面をろ過膜で被覆し該ろ過膜の少なくとも1ケ
所にろ液流出口を設けた膜ユニツトの複数個を重ね合せ
、体液流入口とろ液出口と体液流出口とを設けたケース
内に配設した体液ろ過装置において、各膜ユニツトのろ
液流出口をケースのろ液流出口に連通させ、かつ一方の
膜ユニツトの芯材を構成する任意の素線とこれに隣接す
る他方の膜ユニツトの芯材を構成する任意の素線とのな
す角度を30〜60°となすように膜ユニツトを配設し
、上記ケースの体液流入口から流入される体液が膜ユニ
ツト間の体液流路を通り、ろ過膜でろ過され、ろ過膜を
介して膜ユニツト内に流入したろ液は網目状芯材の間隙
を通過し、さらに膜ユニツトのろ液流出口を経てケース
のろ液出口から流出し、一方体液流路を通つたろ過残液
はケースの体液流出口から流出するようにしたことを特
徴とする体液ろ過装置。 2 芯材のオープニングは、700〜1300μである
特許請求の範囲第1項記載の体液ろ過装置。 3 芯材は、糸径300〜350μの素線を1cm当り
の糸数7〜9本の割合で編んでなる特許請求の範囲第1
項又は第2項記載の体液ろ過装置。 4 ろ過膜は、芳香族ポリアミドを主成分とする分画分
子量20000〜65000で膜厚30〜300μの膜
からなり、ポリエチレン、ポリプロピレンの不織布から
なる膜支持体を裏打ちしてなる特許請求の範囲第1項記
載の体液ろ過装置。 5 ケース内の膜ユニツトは、気密に摺接するピストン
を介して弾性部材で押圧されてなる特許請求の範囲第1
項記載の体液ろ過装置。
[Scope of Claims] 1. A membrane unit in which the entire surface of a mesh-like core material that allows filtrate to pass through gaps within the core material is covered with a filtration membrane, and a filtrate outlet is provided at at least one location on the filtration membrane. In a body fluid filtration device in which a plurality of membrane units are stacked one on top of the other and arranged in a case provided with a body fluid inlet, a filtrate outlet, and a body fluid outlet, the filtrate outlet of each membrane unit is communicated with the filtrate outlet of the case. , and the membrane unit is arranged so that an angle between an arbitrary strand constituting the core material of one membrane unit and an arbitrary strand constituting the core material of the other membrane unit adjacent thereto is 30 to 60°. The body fluid flowing in from the body fluid inlet of the case described above passes through the body fluid flow path between the membrane units, is filtered by the filtration membrane, and the filtrate that flows into the membrane unit via the filtration membrane passes through the mesh core. The filtrate passes through the gap between the materials, passes through the filtrate outlet of the membrane unit, and flows out of the filtrate outlet of the case, while the residual filtrate that has passed through the body fluid channel flows out of the body fluid outlet of the case. Characteristic body fluid filtration device. 2. The body fluid filtration device according to claim 1, wherein the opening of the core material is 700 to 1300μ. 3. The core material is made by knitting wires with a thread diameter of 300 to 350μ at a ratio of 7 to 9 threads per cm.
The body fluid filtration device according to item 1 or 2. 4. The filtration membrane is made of aromatic polyamide as a main component, has a molecular weight cut-off of 20,000 to 65,000, and has a thickness of 30 to 300μ, and is lined with a membrane support made of a nonwoven fabric of polyethylene or polypropylene. The body fluid filtration device according to item 1. 5. The membrane unit in the case is pressed by an elastic member via a piston that slides in airtight contact.
Body fluid filtration device as described in section.
JP55100663A 1980-07-23 1980-07-23 body fluid filtration device Expired JPS6026546B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP55100663A JPS6026546B2 (en) 1980-07-23 1980-07-23 body fluid filtration device
AU72834/81A AU526959B2 (en) 1980-07-23 1981-07-14 Blood filter with multi-mesh-core layers and residue outlet
US06/283,518 US4401566A (en) 1980-07-23 1981-07-18 Body fluid-filtering device
EP81105701A EP0045033B1 (en) 1980-07-23 1981-07-20 Body fluid-filtering device
DE8181105701T DE3172606D1 (en) 1980-07-23 1981-07-20 Body fluid-filtering device
ES504111A ES8204298A1 (en) 1980-07-23 1981-07-20 Body fluid-filtering device.
CA000382020A CA1174606A (en) 1980-07-23 1981-07-20 Body fluid-filtering device
BE0/205460A BE889694A (en) 1980-07-23 1981-07-22 DEVICE FOR FILTERING A FLUID OF THE ORGANISM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55100663A JPS6026546B2 (en) 1980-07-23 1980-07-23 body fluid filtration device

Publications (2)

Publication Number Publication Date
JPS5725858A JPS5725858A (en) 1982-02-10
JPS6026546B2 true JPS6026546B2 (en) 1985-06-24

Family

ID=14280025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55100663A Expired JPS6026546B2 (en) 1980-07-23 1980-07-23 body fluid filtration device

Country Status (2)

Country Link
JP (1) JPS6026546B2 (en)
BE (1) BE889694A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9879748B2 (en) * 2013-03-15 2018-01-30 Tenneco Automotive Operating Company Inc. Two position valve with face seal and pressure relief port

Also Published As

Publication number Publication date
BE889694A (en) 1981-11-16
JPS5725858A (en) 1982-02-10

Similar Documents

Publication Publication Date Title
US4401566A (en) Body fluid-filtering device
CN101505811B (en) Device for removing fluid from blood in a patient
EP1582228B2 (en) Method of removing leukocytes, leukocyte-removing filter and utilization thereof
US8900462B2 (en) Method for removing leukocyte and filter for use therein
CN102089020A (en) Blood dialyzing apparatus
US7758533B2 (en) Hemofiltration systems, methods and devices for treatment of chronic and acute diseases
WO2012039400A1 (en) Blood processing filter and method for producing blood processing filter
JPS6046983B2 (en) blood processing equipment
JP5680675B2 (en) Blood processing filter and method for priming blood processing filter
US20110240549A1 (en) Filter for processing blood
US20150265756A1 (en) Blood treatment filter, blood circuit, and blood treatment method
JPS6026546B2 (en) body fluid filtration device
CA2954323C (en) Filter module
KR101080548B1 (en) A filter for a cartridge, a cartridge, use of a filter in a cartridge and a system for preparing a liquid solution for a medical procedure
IE55496B1 (en) Plasmapheresis by reciprocatory pulsatile filtration
EP3416699A1 (en) Systems and methods for increasing convective clearance of undesired particles in a microfluidic device
JPS606661B2 (en) body fluid filtration device
US9132225B2 (en) Cardiopulmonary bypass circuit including a filtration device
JPS6315860B2 (en)
EP3407932B1 (en) Filter for purifying blood
US20200069874A1 (en) In-body perfusion system
JPS64940Y2 (en)
JPS5928966A (en) Serum separating apparatus
JPS6257349B2 (en)
JPS61193669A (en) Serum treatment apparatus